FRANKFURT: German chemicals group BASF has shut down production of ibuprofen at its plant in Bishop, Texas because of a technical problem, a spokesman for BASF said.
The spokesman said it could take until early September to fix the problem at the plant, where ibuprofen production has been shut down since June 3.
BASF last year announced plans to invest around 200 million euros ($232.74 million) in a new ibuprofen plant at its headquarters in Ludwigshafen in Germany and to expand the Bishop site’s production capacity.
It said at the time that the investment would make it the only company worldwide making ibuprofen at more than one plant. The new facility in Germany is scheduled to come online in 2021.
(Reporting by Maria Sheahan. Editing by Jane Merriman)
Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at email@example.com Contact no. 011-43720751